Table 2.
Other Substance Usage Within Past 30 Days Reported by Medical Cannabis Patients (N = 303)
| Substance | Reported Usage | Percent of Survey Participants |
|---|---|---|
| Opioid Pharmaceuticals | 18 | 5.95% |
| Hallucinogens | 11 | 3.63% |
| MDMA/Ecstasy | 10 | 3.30% |
| Cocaine/Crack Cocaine | 7 | 2.31% |
| Benzodiazepine Pharmaceuticals | 6 | 1.98% |
| Other Substances | 5 | 1.65% |
| Stimulant Pharmaceuticals | 3 | 0.99% |
| Methamphetamine | 2 | 0.66% |
| Heroin | 0 | 0.00% |
Opioid pharmaceuticals may include Vicodin, Percocet, Codeine, Hydrocodone, Oxycodone, Buprenorphine, Fentanyl, etc. Hallucinogens may include psilocybin mushrooms, mescaline, LSD, etc. Benzodiazepine pharmaceuticals may include Valium, Ativan, Xanax, Klonopin, Rohypnol, etc. Stimulant pharmaceuticals may include Concerta, Adderall, Dexedrine, Ritalin, etc.